Company History

  • 2017

    ACIST Medical Systems Announces Approval and Launch of Next-Generation FFR System
    Read More

  • 2017

    ACIST Medical Systems Honored for Delivering ‘World‐Class’ Customer Service for the 8th Consecutive Year Receives Omega’s prestigious NorthFace ScoreBoard Award for exceeding customer expectations
    Read More

  • 2017

    ACIST Launches Direct Sales of its CVi Contrast Delivery System in Japan
    Read More

  • 2017

    ACIST Medical Systems Appoints Bradley Fox as New President and CEO
    Read More

  • 2017

    Impact of Post-Intervention Fractional Flow Reserve Measurement on Acute PCI Outcomes Investigated in Large Independent Registry
    Read More

  • 2017

    Head-to-Head Study Validates Consistent Performance of Microcatheter FFR
    Read More

  • 2017

    ACIST Japan Launches ACIST HDi® High Definition IVUS
    Read More

  • 2017

    Enrollment Complete for ACIST-FFR Multi-Center Study
    Read More

  • 2016

    ACIST Medical Systems Adds Junichi Osawa to International Team

  • 2015

    High Definition IVUS Imaging Has Arrived

  • 2015

    Enrollment in the ACIST‐FFR Multi‐Center Study Has Begun 

  • 2014

    ACIST launches the RXi™ Rapid Exchange FFR System

  • 2014

    ACIST RXi® Rapid Exchange FFR system to be showcase in live case transmissions at EuroPCR

  • 2014

    ACIST enters co-promotion agreement with Medtronic to commercialize next generation FFR and IVUS technologies in the U.S.

  • 2014

    ACIST Launches HDi™ high-definition IVUS

  • 2013

    ACIST launches new brand at TCT 2013

  • 2011

    Receives second NorthFace ScoreBoard AwardSM from Omega for World-Class Customer Service.

    Facilitates diagnosis of 10 millionth patient.

  • 2010

    Receives NorthFace ScoreBoard AwardSM from Omega Management Group for Exemplary Customer Service.

    Thomas Morizio is named president and Chief Operating Officer of ACIST Medical Systems.

  • 2008

    Receives the 2007 Frost & Sullivan Technology Innovation Award.

    Invests in minimally-invasive heart valve technology developed by Heart Leaflet Technologies, Inc.

    Acquires  EMPOWER™ Contrast Injection Systems, IRiS contrast management system.

    Hosts grand opening celebration for its new corporate headquarters.

  • 2007

    Moves to new headquarters in Eden Prairie, Minnesota, increasing manufacturing and product development capabilities and supporting regional offices in Europe and Asia.

  • 2006

    More than 2,000 ACIST systems are installed worldwide.

  • 2005

    Launches the ACIST CVi® Contrast Delivery System, combining the capabilities of the CMS and Voyager® into one integrated system.

  • 2004

    One thousand ACIST systems are being used in more than 30 countries worldwide.

  • 2003

    ACIST Europe office moves to Maastricht and Sittard, Netherlands, and becomes the Customer Service and Distribution Center.

  • 2001

    Receives FDA clearance to market the ACIST Voyager® System for peripheral procedures.

    Acquired by Milan, Italy-based Bracco Group, a world leader in the field of diagnostic imaging.

  • 2000

    Opens a European sales and service office in Ravenswade, Netherlands.

    Receives FDA clearance to market the ACIST CMS2000, featuring a contrast syringe that can be used for up to five procedures.

    Four hundred ACIST systems are being used worldwide.

  • 1998

    Renamed ACIST (Automated Contrast Injection System Technology) Medical Systems to better reflect the company’s focus.

  • 1997

    Licenses five-year marketing rights to New Jersey-based Bracco Diagnostics Inc., which has a nationwide distribution network.

    Receives FDA clearance to market the CL100H system, the first injection system for diagnostic and interventional cardiology.

  • 1995

    Incorporates as Invasatec.

  • 1991

    Company is founded by Dr. Robert F. (Bob) Wilson, Professor of Medicine and Director of the Interventional Cardiology Program at the University of Minnesota.